Secondary neoplasms of the urinary system and male genital organs

BJU International

Volumn 104, Issue 6, 2009, Pages 770-776

  Morichetti, Doriana ^a   Mazzucchelli, Roberta ^a   Lopez Beltran, Antonio ^b   Cheng, Liang ^c   Scarpelli, Marina ^a   Kirkali, Ziya ^d   Montorsi, Francesco ^e   Montironi, Rodolfo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Male genital organs; Metastasis; Secondary tumours; Urinary system

Indexed keywords

TUMOR MARKER;

BLADDER METASTASIS; BLADDER TUMOR; BREAST TUMOR; COLORECTAL TUMOR; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY METASTASIS; LOCAL METASTASIS; LUNG TUMOR; MALE GENITAL SYSTEM; MELANOMA; METASTASIS; NEEDLE BIOPSY; PENIS TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROSTATE TUMOR; SHORT SURVEY; TESTIS TUMOR; THYROID CANCER; TRISOMY 7; URINARY TRACT; UTERINE CERVIX CANCER;

DIAGNOSIS, DIFFERENTIAL; GENITAL NEOPLASMS, MALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; UROLOGIC NEOPLASMS;

EID: 69249099722     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08746.x     Document Type: Short Survey

References (49)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96
2. Bates AW, Baithun SI. The significance of secondary neoplasms of the urinary and male genital tract. Virchows Arch 2002 440 : 640 647
3. Honda H, Coffman CE, Berbaum KS, Barloon TJ, Masuda K. CT analysis of metastatic neoplasms of the kidney. Comparison with primary renal cell carcinoma. Acta Radiol 1992 33 : 39 44
4. Klatte T, Rao JY, Ribas A, Pantuck AJ. Metastatic melanoma to the kidney presenting with renal vein tumor thrombus. Urology 2007 69 : 982.e7 9
5. Wagle DG, Moore RH, Murphy GP. Secondary carcinomas of the kidney. J Urol 1975 114 : 30 2
6. Martignoni G, Brunelli M, Gobbo S et al. Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Anal Quant Cytol Histol 2007 29 : 41 9
7. Jung SJ, Chung JI, Park SH, Ayala AG, Ro JY. Thyroid follicular carcinoma-like tumor of kidney: a case report with morphologic, immunohistochemical, and genetic analysis. Am J Surg Pathol 2006 30 : 411 415
8. Gupta R, Viswanathan S, D'Cruz A, Kane SV. Metastatic papillary carcinoma of thyroid masquerading as a renal tumour. J Clin Pathol 2008 61 : 143
9. Bates AW, Baithun SI. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology 2000 36 : 32 40
10. Helpap B, Ayala AG, Grignon DJ, Oliva E, Epstein JI. Metastatic tumours and secondary extension in urinary bladder. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA, The World Health Organization Classification of Tumours of the Urinary System and Male Genital System. Lyon, France : IARC Press, 2004 : 148 149
11. Silver SA, Epstein JI. Adenocarcinoma of the colon simulating primary urinary bladder neoplasia. A report of nine cases. Am J Surg Pathol 1993 17 : 171 178
12. Velcheti V, Govindan R. Metastatic cancer involving bladder: a review. Can J Urol 2007 14 : 3443 3448
13. Lopez-Beltran A. Immunohistochemical markers in evaluation of urinary and bladder tumors. Anal Quant Cytol Histol 2007 29 : 121 122 (Pubitemid 46649490)
14. Raspollini MR, Nesi G, Baroni G, Girardi LR, Taddei GL. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl Immunohistochem Mol Morph 2005 13 : 358 362
15. Requena MJ, Alvarez-Kindelan J, Blanca A. Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review. Anal Quant Cytol Histol 2007 29 : 380 382
16. Tamboli P, Mohsin SK, Hailemariam S, Amin MB. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Laboratory Med 2002 126 : 1057 1063
17. Chuang A-Y, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI. Immunohistochemical differentiation of high -grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol 2007 31 : 1246 1255
18. Baldwin L, Lee AH, Al-Talib RK, Theaker JM. Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinoma. Histopathology 2005 46 : 50 6
19. Zagha RM, Hamawy KJ. Solitary breast cancer metastasis to the bladder: an unusual occurrence. Urol Oncol 2007 25 : 236 239
20. Bates AW, Baithun SI. Secondary solid neoplasms of the prostate: a clinico-pathological series of 51 cases. Virchows Arch 2002 440 : 392 396
21. Zein TA, Huben R, Lane W, Pontes JE, Englander LS. Secondary tumors of the prostate. J Urol 1985 133 : 615 616
22. Owens C, Epstein JI, Netto GJ. Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry. Arch Pathol Laboratory Med 2007 131 : 599 603
23. Osunkoya AO, Netto GJ, Epstein JI. Colorectal adenocarcinoma involving the prostate: report of 9 cases. Hum Pathol 2007 38 : 1836 1841
24. Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol 2006 19 : 1528 1535
25. Feil G, Maurer S, Nagele U et al. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue. Eur Urol 2008 53 : 1066 1072
26. Mai KT, Collins JP, Veinot JP. Prostatic adenocarcinoma with urothelial (transitional cell) carcinoma features. Appl Immunohistochem Mol Morph 2002 10 : 231 236
27. Oxley J, Abbott C. Thrombomodulin immunostaining and ductal carcinoma of the prostate. Histopathology 1998 33 : 391 392
28. Thalmann GN. Prognostic markers for bladder cancer - are we there yet? Eur Urol 2007 51 : 591 592
29. Varma M, Morgan M, Amin MB, Wozniak S, Jasani B. High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology 2003 42 : 167 172
30. Vrooman OP, Witjes JA. Urinary markers in bladder cancer. Eur Urol 2008 53 : 909 916
31. Njinou Ngninkeu B, Lorge F, Moulin P, Jamart J, Van Cangh PJ. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol 2003 169 : 149 152
32. Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 2006 37 : 726 734
33. Mostofi FK, Price EB. Tumors of the Male Genital System, 2nd edn. Washington DC : AFIP, 1973
34. Haupt HM, Mann RB, Trump DL, Abeloff MD. Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms. Cancer 1984 54 : 709 714
35. Damjanov I. Tumors of the testis and epididymis. In Murphy WM Urological Pathology. Philadelphia : WB Saunders 1997 : 385 386
36. Kirkali Z, Reid R, Deane RF, Kyle KF. Silent testicular metastasis from carcinoma of the prostate. Br J Urol 1990 66 : 205 207
37. Ulbright TM, Young RH. Metastatic carcinoma to the testis: a clinicopathologic analysis of 26 nonincidental cases with emphasis on deceptive features. Am J Surg Pathol 2008 32 : 1683 1693
38. van Casteren NJ, Stoop H, Dohle GR, de Wit R, Oosterhuis JW, Looijenga LH. Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. Eur Urol 2008 54 : 153 158
39. Vidal-Jimenez A. New immunohistochemical markers in testicular tumors. Anal Quant Cytol Histol 2007 29 : 377
40. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 2004 28 : 935 940
41. Cheng L. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 2004 101 : 2006 2010
42. Sung MT, Jones TD, Beck BD, Foster RS, Cheng L. OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy. Hum Pathol 2006 37 : 662 667
43. Cheng L, Sung MT, Cossu-Rocca P et al. OCT4. Biological functions and clinical applications as marker of germ cell neoplasia. J Pathol 2007 211 : 1 9
44. Kernek KM, Brunelli M, Ulbright TM et al. Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumors. Mod Pathol 2004 17 : 1309 1313
45. Cheng L, Zhang S, MacLennan GT et al. Interphase fluorescence in situ hybridization analysis of chromosome 12p abnormalities is useful for distinguishing epidermoid cyst of the testis from pure mature teratoma. Clin Cancer Res 2006 12 : 5668 5772
46. Perez-Mesa C, Oxenhandler R. Metastatic tumors of the penis. J Surg Oncol 1989 42 : 11 5
47. Mukamel E, Farrer J, Smith RB, deKernion JB. Metastatic carcinoma to penis: when is total penectomy indicated? Urology 1987 29 : 15 8
48. Ro JY, Kim KR, Amin MB, Ayala AG. Penis and scrotum. In Bostwick DG, Cheng L. Urologic Surgical Pathology. New York : Elsevier / Mosby, 2008 : 891 952
49. Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla AL. Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra and Penis. Fascicle 28, 3rd edn. Washington DC : AFIP, 2000